Predicted to enable type 1 cannabinoid receptor binding activity. Predicted to be active in plasma membrane. Is expressed in heart; liver; nervous system; and pleuroperitoneal region. Orthologous to human CNRIP1 (cannabinoid receptor interacting protein 1).